Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07752979
PHASE2

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Sponsor: AbbVie

View on ClinicalTrials.gov

Summary

Obesity is a condition where a person has excessive body fat, defined by a body mass index (BMI) of 30 kg/m2 or higher. The goal of this study is to evaluate the effect of various doses of ABBV-295 compared to placebo on reducing body weight at Week 32 in participants with obesity or overweight with weight-related comorbidities. ABBV-295 is an investigational long-acting amylin analog being developed for chronic weight management. Participants are placed into multiple treatment groups with different dosing paradigms of ABBV-295 or placebo. Participants will not know which treatment they are receiving, and there is a chance of being assigned to placebo. Adults with obesity or overweight (as defined by BMI) with weight-related comorbidities will be enrolled. Approximately 360 participants will be enrolled in the study at approximately 70 sites in the United States and Puerto Rico. Participants will receive subcutaneous (SC) injections of ABBV-295 solution for injection or matching placebo administered via pre-filled syringes for 52 weeks during the Double-Blind Period. There may be higher treatment burden for participants in this trial compared to their standard of care due to study procedures. Participants will attend regular visits during the study at a hospital or clinic. The effects of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

Official title: A Phase 2 Dose-Finding Study to Assess the Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

360

Start Date

2026-08-04

Completion Date

2028-03

Last Updated

2026-08-31

Healthy Volunteers

No

Interventions

DRUG

ABBV-295

Subcutaneous

DRUG

Placebo

Subcutaneous

Locations (33)

Headlands Research - Scottsdale /ID# 282571

Scottsdale, Arizona, United States

Southern California Dermatology /ID# 282011

Santa Ana, California, United States

Encompass Clinical Research /ID# 282483

Spring Valley, California, United States

Diablo Clinical Research /ID# 282530

Walnut Creek, California, United States

Innovative Research of West Florida /ID# 281963

Clearwater, Florida, United States

Altus Clinical Research - Lake Worth - South Congress Avenue /ID# 281979

Lake Worth, Florida, United States

South Broward Research /ID# 282125

Miramar, Florida, United States

Charter Research - Winter Park /ID# 281968

Orlando, Florida, United States

Florida Institute For Clinical Research /ID# 282739

Orlando, Florida, United States

Progressive Medical Research /ID# 282838

Port Orange, Florida, United States

Charter Research - The Villages /ID# 282376

The Villages, Florida, United States

Metabolic Research Institute /ID# 282350

West Palm Beach, Florida, United States

Encore Medical Research - Weston /ID# 282044

Weston, Florida, United States

Elite Clinical Trials - Blackfoot /ID# 282042

Blackfoot, Idaho, United States

L-MARC Research Center /ID# 282008

Louisville, Kentucky, United States

Studymetrix Research /ID# 282163

City of Saint Peters, Missouri, United States

Medication Management /ID# 281965

Greensboro, North Carolina, United States

Monroe Biomedical Research /ID# 282009

Monroe, North Carolina, United States

Centricity Research - Morehead city /ID# 283264

Morehead City, North Carolina, United States

Lucas Research - New Bern /ID# 282747

New Bern, North Carolina, United States

Accellacare - Tradd Court - Wilmington /ID# 282200

Wilmington, North Carolina, United States

Lillestol Research LLC /ID# 281978

Fargo, North Dakota, United States

CTI Clinical Research Center /ID# 282043

Cincinnati, Ohio, United States

Holston Medical Group - Bristol /ID# 282045

Bristol, Tennessee, United States

New Phase Research & Development /ID# 282131

Knoxville, Tennessee, United States

Summit Medical Group- Halls Family Physicians /ID# 282435

Knoxville, Tennessee, United States

Clinical Research Associates - Nashville /ID# 282161

Nashville, Tennessee, United States

Velocity Clinical Research - Dallas /ID# 282734

Dallas, Texas, United States

Dcol Center For Clinical Research /ID# 281961

Longview, Texas, United States

Washington Center For Weight Management And Research /ID# 282047

Arlington, Virginia, United States

Sovah Health - Danville /ID# 282876

Danville, Virginia, United States

Health Research Of Hampton Roads /ID# 282014

Newport News, Virginia, United States

National Clinical Research /ID# 282007

Richmond, Virginia, United States